Physician profile
Lauren E Wong
NPI 1760642912
$1,084.80
in general payments reported to CMS, 2019-2025
10 companies · $741 in 2025
The $741 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.16 · 2022: $189 · 2023: $102 · 2024: $39.20 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $316.42 | 2025 | |
| Integra Lifesciences Corporation | $155.93 | 2025 | Integra, Surgimend, Omnigraft |
| Janssen Biotech, INC. | $131.70 | 2021-2025 | Tremfya |
| Abbvie INC. | $122.43 | 2025 | |
| Amgen INC. | $110.30 | 2022-2025 | Evenity, Tavneos, Enbrel |
| Glaxosmithkline, LLC. | $97.51 | 2022-2023 | Benlysta |
| Novartis Pharmaceuticals Corporation | $62.19 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $42.04 | 2022 | |
| Ucb, INC. | $30.36 | 2023 | Cimzia |
| Biocon Biologics INC | $15.92 | 2024 | Hulio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.